Human biopsy-defined ischemia-reperfusion injury-selective reperfusion signature prioritizes reperfusion-timed mitogen-activated protein kinase kinase inhibition after donation after circulatory death liver transplantation.

Zhao Y, Hou D, Xiong B, Hou M, Song P, Dong Z, Gao Y, Jia Z, Xue H, Jia D

DOI: 10.1016/j.ajt.2026.06.025
Published: 2026 Jul 2
Container: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ajt.2026.06.025,
  title = {Human biopsy-defined ischemia-reperfusion injury-selective reperfusion signature prioritizes reperfusion-timed mitogen-activated protein kinase kinase inhibition after donation after circulatory death liver transplantation.},
  author = {Zhao Y and Hou D and Xiong B and Hou M and Song P and Dong Z and Gao Y and Jia Z and Xue H and Jia D},
  year = {2026},
  journal = {American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons},
  doi = {10.1016/j.ajt.2026.06.025},
  url = {https://doi.org/10.1016/j.ajt.2026.06.025}
}

RIS

TY  - JOUR
TI  - Human biopsy-defined ischemia-reperfusion injury-selective reperfusion signature prioritizes reperfusion-timed mitogen-activated protein kinase kinase inhibition after donation after circulatory death liver transplantation.
AU  - Zhao Y
AU  - Hou D
AU  - Xiong B
AU  - Hou M
AU  - Song P
AU  - Dong Z
AU  - Gao Y
AU  - Jia Z
AU  - Xue H
AU  - Jia D
PY  - 2026
JO  - American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
DO  - 10.1016/j.ajt.2026.06.025
UR  - https://doi.org/10.1016/j.ajt.2026.06.025
ER  -

APA

Y, Z., D, H., B, X., M, H., P, S., Z, D., Y, G., Z, J., H, X., & D, J. (2026). Human biopsy-defined ischemia-reperfusion injury-selective reperfusion signature prioritizes reperfusion-timed mitogen-activated protein kinase kinase inhibition after donation after circulatory death liver transplantation.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. https://doi.org/10.1016/j.ajt.2026.06.025

Source records

pubmed · retrieved 2026-09-27T14:34:00.568Z
europe-pmc · retrieved 2026-09-27T14:34:00.592Z